Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
EARLY_PHASE1
INTERVENTIONAL
2016-01-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxytocin Effects on the Tolerance of Infidelity
NCT02733237
The Influence of Intranasal Oxytocin on Communication
NCT02415920
The Effect of Oral Oxytocin and Atosiban on Social Attention
NCT07093060
Oxytocin and Social Behavior Over the Lifespan
NCT00914953
Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II
NCT02652195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oxytocin
Intranasal 24 IU oxytocin self-administration.
Oxytocin
Intranasal oxytocin is hypothesized to amplify the influence of social norms on unethical behavior.
placebo
Intranasal placebo. 125 mg of 0.5% cholorobutanol to 50 ml saline, with approximately 5 pH. The solution will then be sterilized using a 0.22 micron filter.
Oxytocin
Intranasal oxytocin is hypothesized to amplify the influence of social norms on unethical behavior.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin
Intranasal oxytocin is hypothesized to amplify the influence of social norms on unethical behavior.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* \_\_\_\_\_History of seizures
* \_\_\_\_\_Neurological Disorder
* \_\_\_\_\_Current psychiatric disorder
* \_\_\_\_\_Previous psychiatric disorder (can be included at discretion of PI)
* Date last episode (if \> 1 year, include; if \<1 year, at discretion of PI)
* \_\_\_\_\_Current use of psychoactive drugs
* \_\_\_\_\_Previous use of psychoactive drugs (can be included at discretion of PI) \_\_\_\_\_Date last medicated\_\_\_\_\_ \_\_\_\_\_Type of medication\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
* \_\_\_\_\_Current use of anticoagulants
* \_\_\_\_\_Current use of corticosteroids
* \_\_\_\_\_Previous head trauma (can be included at discretion of PI)
* \_\_\_\_\_Alcoholism or substance abuse
* \_\_\_\_\_Carcinoma of the breast or prostate
* \_\_\_\_\_Renal or Hepatic diseases
* \_\_\_\_\_Chronic lung diseases
* \_\_\_\_\_Cancer
* \_\_\_\_\_Liver problems
* \_\_\_\_\_Hypertension/Cardiac diseases
* \_\_\_\_\_Cardiovascular Disease
* \_\_\_\_\_Nephritis
* \_\_\_\_\_Diabetes (use of insulin) /Obesity
* \_\_\_\_\_Endocrine disease or malignancy
* \_\_\_\_\_Asthma (can be included as discretion of study physician/designee, if episodes are infrequent, nonmedicated, and no active problems at time of study)
* Medication
* Frequency of episodes\_\_\_\_ \_\_\_\_\_Date of last episode\_\_\_\_\_
* \_\_\_\_\_Migraines(can be included as discretion of study physician/designee, if episodes are infrequent, nonmedicated, and no active problems at time of study)
* Medication \_\_\_\_\_Frequency of migraines\_\_\_\_\_ \_\_\_\_\_Date of last migraine\_\_\_\_\_
* \_\_\_\_\_High levels of physical contact with women or children
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard University
OTHER
University of Texas at Austin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert A Josephs, PhD
Role: PRINCIPAL_INVESTIGATOR
utaustin
References
Explore related publications, articles, or registry entries linked to this study.
Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005 Jun 2;435(7042):673-6. doi: 10.1038/nature03701.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-11-0033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.